Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (14 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenues
71
82
94
98
109
79
74
Cost of sales
42
47
50
57
63
44
45
Selling, general and administrative
32
31
33
33
36
35
31
Gain on revaluation of ACT liability
-1
-1
-1
0
0
0
0
Research and development
1
1
1
3
2
1
4
Goodwill and intangible assets impairment
0
0
0
0
0
23
1
Total costs and expenses
74
78
84
92
101
104
82
Operating (loss) income
-3
4
10
5
8
-25
-8
Interest expense
0
0
0
0
0
0
0
Interest income
0
0
0
0
0
0
0
Other expense
0
0
0
0
0
-1
0
(Loss) income before taxes
-3
4
9
5
8
-26
-9
Income tax (expense) benefit
1
-2
-3
-2
-3
8
-4
Net (loss) income
-2
2
6
3
5
-18
-12
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (35 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
31
28
24
28
19
22
Restricted cash
n/a
0
0
0
0
0
0
Marketable securities
n/a
0
0
0
0
0
0
Accounts receivable, net
n/a
21
34
30
37
32
23
Inventories
n/a
1
0
1
0
1
2
Prepaid expenses and other current assets
n/a
2
2
4
2
4
4
Prepaid income taxes
n/a
0
0
0
0
0
2
Income taxes receivable
n/a
0
1
0
1
1
0
Deferred income taxes
n/a
0
0
1
0
2
0
Total current assets
n/a
54
66
60
69
58
52
Property and equipment, net
n/a
14
14
14
13
14
12
Goodwill
n/a
21
21
21
21
2
2
Other intangible assets, net
n/a
6
5
5
4
10
7
Deferred income taxes
n/a
5
4
4
0
6
1
Other assets
n/a
2
3
3
2
1
1
Total assets
n/a
103
113
106
110
91
76
Liabilities and owners' equity
Short-term debt
n/a
2 2269000
1 1181000
0 0
2 1636000
2 1625000
0 0
Accounts payable
n/a
8 7516000
10 10476000
13 12828000
10 9920000
7 7310000
9 8942000
Employee compensation
n/a
3 2863000
5 4902000
3 3175000
4 4460000
2 2007000
2 1645000
Income taxes payable
n/a
2 1857000
0 0
0 0
0 0
0 0
0 0
Other accrued liabilities
n/a
3 3306000
6 6071000
5 4943000
5 4630000
8 7708000
6 5949000
Total current liabilities
n/a
18 17811000
23 22630000
21 20946000
21 20646000
19 18650000
17 16536000
Deferred income taxes
n/a
0 0
0 0
0 0
0 59000
0 0
0 0
Other liabilities
n/a
1 1482000
1 1347000
1 715000
1 730000
1 520000
1 501000
Total liabilities
n/a
19 19293000
24 23977000
22 21661000
21 21435000
19 19170000
17 17037000
Commitments and contingencies (Note 9)
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
0 242000
0 237000
0 221000
0 227000
0 230000
0 234000
Additional paid-in capital
n/a
129 129424000
132 132350000
133 133498000
133 132796000
135 134985000
135 135394000
Accumulated deficit
n/a
-46 -46075000
-44 -44031000
-49 -49128000
-44 -44027000
-62 -61752000
-74 -74132000
Accumulated other comprehensive loss
n/a
0 243000
0 381000
0 -392000
0 37000
0 -448000
-2 -1556000
Nil coupon perpetual loan notes
n/a
0 76000
0 76000
0 76000
0 76000
0 76000
0 76000
Treasury stock
n/a
0 0
0 0
0 -39000
0 -486000
-1 -790000
-1 -1042000
Total stockholders’ equity
n/a
84 83910000
89 89013000
84 84236000
89 88623000
72 72301000
59 58974000
Total liabilities and stockholders’ equity
n/a
103 103203000
113 112990000
106 105897000
110 110058000
91 91471000
76 76011000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Aug 9, 2016 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (35 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net (loss) income
-2
2
6
3
5
-18
-12
Depreciation
4
3
3
2
2
2
2
Amortization
1
1
1
1
1
2
2
Gain on disposal of equipment
0
0
0
0
0
0
0
Gain on revaluation of ACT liability
0
-1
-1
0
0
0
0
Unrealized holding loss on marketable securities
0
0
0
0
0
0
0
Allowance for doubtful accounts
0
0
0
0
1
1
0
Deferred income taxes
-1
-1
1
0
1
-10
5
Stock compensation expense
6
4
3
1
2
2
2
Goodwill and intangible assets impairment
0
0
0
0
0
23
1
Accounts receivable
5
-3
-13
4
-7
6
8
Inventories
1
0
1
0
0
-1
-1
Prepaid expenses, other current assets and other noncurrent assets
3
0
-1
-2
2
-1
-1
Accounts payable
-2
2
3
2
-3
-4
2
Accrued liabilities and other noncurrent liabilities
0
5
2
-3
-1
1
-1
Other
0
0
0
0
0
0
0
Net cash provided by operating activities
14
12
5
9
3
5
7
Increase in restricted cash
0
0
0
0
0
0
0
Purchases of property, equipment and patents
-2
-2
-2
-3
-2
-3
-1
Proceeds from the sale of equipment
0
0
0
0
0
0
0
Purchases of other intangible assets
0
0
0
0
0
-3
0
Payment for acquisitions, net of cash acquired
-20
0
0
0
0
-8
0
Net cash used in investing activities
-22
-2
-2
-3
-2
-14
-1
Net proceeds (payments) of short-term debt
1
-1
-1
-1
2
0
-2
Proceeds from exercises of stock options
1
0
0
0
1
0
0
Excess tax benefit from exercises of stock options
0
0
0
0
0
0
0
Reclassification of liability award
0
0
0
0
0
0
0
Repurchases of common stock
0
0
-4
-8
0
0
0
Other
0
0
0
0
0
0
0
Treasury shares withheld
0
0
0
0
0
0
0
Net cash provided by (used in) financing activities
2
-1
-5
-9
2
0
-2
Effect of exchange rate fluctuations on cash
0
0
0
-1
0
-1
-1
Net (decrease) increase in cash and cash equivalents
-7
10
-2
-4
3
-9
3
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 10, 2014 n/a
calculated values,
restated on Mar 16, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo